solifenacin succinate has been researched along with dutasteride in 3 studies
| Studies (solifenacin succinate) | Trials (solifenacin succinate) | Recent Studies (post-2010) (solifenacin succinate) | Studies (dutasteride) | Trials (dutasteride) | Recent Studies (post-2010) (dutasteride) |
|---|---|---|---|---|---|
| 522 | 194 | 343 | 728 | 188 | 480 |
| Protein | Taxonomy | solifenacin succinate (IC50) | dutasteride (IC50) |
|---|---|---|---|
| 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | Homo sapiens (human) | 0.004 | |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | Homo sapiens (human) | 0.0001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hagiwara, M; Hasegawa, M; Ishioka, K; Kikuchi, E; Maeda, T; Miyajima, A; Miyazaki, Y; Oya, M; Shinojima, T | 1 |
| Gainullina, Y; Karashchuk, E; Kosilov, K; Kosilova, L; Kuzina, I; Kuznetsov, V; Loparev, S; Prokofyeva, A | 1 |
| Kaplan, SA | 1 |
1 trial(s) available for solifenacin succinate and dutasteride
| Article | Year |
|---|---|
The Risk of Sexual Dysfunction and Effectiveness of Treatment of Benign Prostatic Hyperplasia With Severe Lower Urinary Tract Dysfunction With Combination of Dutasteride and Solifenacin.
Topics: Drug Therapy, Combination; Dutasteride; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Severity of Illness Index; Solifenacin Succinate; Surveys and Questionnaires; Treatment Outcome; Urological Agents | 2018 |
2 other study(ies) available for solifenacin succinate and dutasteride
| Article | Year |
|---|---|
Solifenacin or mirabegron could improve persistent overactive bladder symptoms after dutasteride treatment in patients with benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Acetanilides; Adrenergic beta-3 Receptor Agonists; Aged; Aged, 80 and over; Azasteroids; Dutasteride; Humans; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Prostatic Hyperplasia; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Thiazoles; Urinary Bladder, Overactive | 2015 |
Re: The Risk of Sexual Dysfunction and Effectiveness of Treatment of Benign Prostatic Hyperplasia with Severe Lower Urinary Tract Dysfunction with Combination of Dutasteride and Solifenacin.
Topics: 5-alpha Reductase Inhibitors; Dutasteride; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Solifenacin Succinate; Urinary Tract | 2020 |